Company: OSRH
Filing Date: 2025-08-19
Form Type: PRE 14A
Source: 0001213900-25-078140
Chunk: 7

Company: OSR Holdings, Inc.
Filing Date: 2025-08-19
Form: PRE 14A
Chunk 7
---
 person, a “Participating Stockholder”),
and each stockholder of OSR that executed a Non-Participating Joinder thereto (each such person, a “Non-Participating Stockholder”,
and together with the Participating Stockholders, the “OSR Stockholders”).

In connection with the Closing of the Business Combination,
we changed our name from Bellevue Life Sciences Acquisition Corp. to OSR Holdings, Inc. and changed the trading symbols of our common
stock and warrants from “BLAC” and “BLACW,” to “OSRH” and “OSRHW,” respectively. In connection
with the Closing, any Units (which were trading under the symbol “BLACU”) that had not yet separated, were separated into
their component shares of common stock and warrants and ceased trading.

At the 2025 Annual Meeting, stockholders will be asked to
vote on several corporate governance and administrative matters related to the post-combination company, including the election of directors,
an advisory vote on executive compensation, the adoption of equity incentive sub-plans under the Company’s Omnibus Plan, and the
approval of a potential financing transaction pursuant to Nasdaq Listing Rule 5635(d). Therefore, our Board is submitting the proposals
described in this proxy statement for the stockholders to vote upon. These proposals are more fully described in this proxy statement.

Why does the Company need to hold an annual meeting?

The meeting is being held to satisfy the annual meeting
requirements of Nasdaq. Nasdaq Listing Rule 5620(a) requires that we hold an annual meeting of stockholders for the election of directors
within 12 months after our fiscal year ended December 31, 2024.

What is being voted on?

You are being asked to vote on each
of the proposals listed below:

| 1. | Proposal 1 — Director Proposal: A proposal to elect seven directors to the Company’s                                                        
 Board of Directors, each to serve until the next annual meeting of stockholders following this Annual Meeting or until each such director’s 
 successor is elected and qualified, subject to his earlier death, resignation or removal.                                                   |

| 2. | Proposal 2 — Executive Compensation Proposal: A proposal to approve, on a non-binding advisory 
 basis, the compensation of the Company’s named executive officers.                             |

<div align='center'>2</div>

| 3. | Proposal 3 — Equity Plan Proposal: A proposal to approve compensation terms and adopt